COMMENTARY
Director's Update: Enabling the Evolution of Oncology
Radio transripts from the 1960s reveal how a relatively new technology, the computer, had begun to alter research and the practice of medicine. "We have made extensive use [of computers] so far, but I think much more lies in the future," said then NCI Director Dr. Carl G Baker during one such interview. "Massive amounts of information accumulate very rapidly." Read more > >
A Conversation with...Dr. Kenneth Buetow
The director of NCI's Center for Biomedical Informatics and Information Technology talks about caBIG®, which provides bioinformatics infrastructure and a portfolio of more than 40 tools that enable organizations and individual researchers to securely share biomedical data. Read more > >
caBIG® Tools and the 21st Century Biomedical Paradigm
This diagram illustrates how the tools that have been developed through NCI's caBIG® project will enable the seamless integration of data from bench to bedside, making cancer research and patient treatment more efficient, and realizing the benefits of personalized medicine.
NEWS
Recovery Act Boosts Bioinformatics
Top federal health information technology officials are predicting that the American Recovery and Reinvestment Act of 2009 will help push development and adoption of health IT and interconnectivity to dramatically new levels over the coming years. Read more > >
Cancer Genomics: Building Haystacks, Finding Needles
Computational algorithms are being used to organize and sift through the recent explosion of genomic information about tumorsElectronic Health Records Emerging as Important Care, Research Tool
Electronic health record systems are beginning to demonstrate their utility in research, and NCI is collaborating with ASCO to develop tools for more widespread adoptionComputational Modeling Paints a Picture of the Future
In silico research can provide substantial time and cost savings to researchers by highlighting the most promising avenues for future researchLearn More
Resources for funding, collaboration, and guidance can be found throughout NCI's divisions, as well as the Department of Health and Human Services
| Subscribe Now! |
HIGHLIGHTS
SUPPLEMENT TO THE SPECIAL ISSUE
Mutant Protein Implicated in Diffuse Large B-cell Lymphoma
Common genetic changes may disable a protein that could block tumorsTesting Breast Tumors May Predict Response to Chemotherapy
Profiling the genes HER2 and TOP2A could help guide the selection of therapiesMore Gene Mutations Found in Childhood Leukemia
Evidence further implicates JAK genes in acute lymphoblastic leukemiaDutasteride May Reduce Prostate Cancer Risk
Preliminary results show the drug cut risk by 23 percent compared to placeboCancer Incidence Could Rise Sharply in Coming Decades
Growing populations of older adults and minorities will drive increase in the U.S.Immunotherapy Improves Survival in Metastatic Prostate Cancer
Therapeutic vaccine shows modest benefit in phase III trial
UPDATES
SUPPLEMENT TO THE SPECIAL ISSUE
Notes
- New HHS Secretary Sworn In
- NCI's Lowy Elected to NAS
- NCI's Ross Wins 2009 Kretchmer Award
- CCR Eminent Lecture Series Features Dr. Andrew Fire
- Telephone Workshop Series for Cancer Survivors
- DCLG Accepting Nominations
- NCI to Highlight Translational Research Resources at 2009 BIO International Convention
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
